Recombinant Chicken Muscarinic acetylcholine receptor M3 (CHRM3)

What is Chicken Muscarinic Acetylcholine Receptor M3 (CHRM3) and what are its primary functions?

Chicken Muscarinic acetylcholine receptor M3 (CHRM3) is a G protein-coupled receptor that mediates various cellular responses in the chicken nervous system and other tissues. Its primary functions include:

• Inhibition of adenylate cyclase

• Breakdown of phosphoinositides

• Modulation of potassium channels through G proteins

• Primary transducing effect is phosphoinositide (Pi) turnover

Unlike mammalian hearts which predominantly express the M2 subtype, chicken heart uniquely expresses three muscarinic receptor subtypes: M2, M3, and M4. This makes chicken CHRM3 particularly interesting for comparative studies of cardiac muscarinic signaling .

How does the structure of chicken CHRM3 compare to mammalian CHRM3 variants?

Studies have revealed significant homology between chicken and mammalian CHRM3:

• The cloned chicken CHRM3 contains an open reading frame coding for a 639 amino acid protein

• It demonstrates 87% homology to the human M3 muscarinic receptor

• It demonstrates 86% homology to the rat M3 muscarinic receptor

This high degree of sequence conservation suggests evolutionary importance of this receptor's function across species. Despite the similarities, the unique expression pattern in chicken heart (expressing M2, M3, and M4) differentiates it from mammalian hearts (primarily expressing M2) .

What methods are available for detecting chicken CHRM3 in experimental samples?

Several methods are available for detecting chicken CHRM3:

ELISA-based detection:

• Commercially available chicken CHRM3 ELISA kits offer high sensitivity and specificity

• These kits typically detect CHRM3 in serum, plasma, cell culture supernatants, and tissue homogenates

• Standard deviation is less than 8% for standards repeated 20 times on the same plate

• Standard deviation is less than 10% when the same sample is measured by different operators

Radioligand binding assays:

• Quinuclidinly benzilate binding can be used to measure CHRM3 expression

• Typical binding parameters: Kd of approximately 76 ± 17 pM

RNase protection assays:

• Effective for demonstrating the presence of M3 muscarinic receptor mRNA in different tissues

• Successfully used to detect CHRM3 mRNA in brain, atria, and ventricle of chicks 17 days in ovo

What are the common challenges when working with recombinant CHRM3 proteins?

Researchers working with recombinant CHRM3 should be aware of several challenges:

• Stability concerns: Repeated freezing and thawing is not recommended for recombinant proteins. Working aliquots should be stored at 4°C for up to one week

• Storage considerations: Liquid form typically has a shelf life of 6 months at -20°C/-80°C, while lyophilized form can be stable for 12 months at -20°C/-80°C

• Expression systems: The choice of expression system (bacterial, yeast, mammalian) can affect protein folding, post-translational modifications, and functionality

• Reconstitution protocols: Proper reconstitution is critical for maintaining protein activity and should follow manufacturer's specific instructions

How can researchers differentiate between M3 and other muscarinic receptor subtypes in pharmacological studies?

Distinguishing between muscarinic receptor subtypes requires careful pharmacological characterization:

Antagonist binding profiles for CHRM3:

When performing binding studies, researchers should consider:

• Using multiple selective antagonists for comparison

• Implementing a two-site binding model for analysis when appropriate

• Analyzing displacement binding curves carefully to distinguish receptor populations

The combined pharmacological profile can help definitively identify the M3 subtype from other muscarinic receptors in experimental systems .

What signaling pathways are activated by chicken CHRM3 and how do they differ from mammalian systems?

Chicken CHRM3 activates several signaling pathways that can be experimentally measured:

Primary signaling pathways:

• Phosphoinositide hydrolysis: M3 receptors couple to PLC with higher efficacy than M2 and M4 receptors

• Cyclic AMP regulation: Carbamylcholine stimulation of CHO-CM3 cells results in a 1.6-fold increase in cyclic AMP accumulation

• Inositol phosphate release: Stimulation leads to a 3.5-fold increase in pertussis toxin-insensitive inositol phosphate release

• Intracellular calcium mobilization: M3 receptors can stimulate a rise in intracellular Ca2+

Unlike mammalian systems where M2 receptors predominantly inhibit adenylyl cyclase, chicken cardiac tissue shows a more complex interplay between M2, M3, and M4 receptors. This creates unique experimental considerations when studying cardiac muscarinic signaling in chicken models .

What experimental approaches are most effective for studying CHRM3-mediated cellular responses in chicken cardiac tissue?

When investigating CHRM3 functions in chicken cardiac tissue, researchers should consider:

Tissue preparation techniques:

• Fresh isolation of cardiac myocytes from atria and ventricle

• Careful age selection (studies show CHRM3 expression in chicks 17 days in ovo)

• Preservation of tissue integrity to maintain receptor expression

Functional assays:

• Measurement of contractile responses in isolated cardiac tissues

• Patch-clamp electrophysiology to study ion channel modulation

• Calcium imaging to detect intracellular calcium changes

• Biochemical assays for second messenger generation (cAMP, inositol phosphates)

Molecular approaches:

• RNase protection assays for mRNA detection

• Receptor binding studies with selective antagonists

• Immunohistochemistry with specific antibodies (when available)

• Signal transduction pathway analysis

The unique expression of multiple muscarinic receptor subtypes in chicken heart makes it essential to use selective agonists/antagonists or gene silencing approaches to isolate CHRM3-specific effects from those mediated by M2 and M4 subtypes .

How can recombinant chicken CHRM3 be effectively produced and characterized for research applications?

Based on successful approaches with human CHRM3 and chicken muscarinic receptors, the following methodology is recommended:

Cloning strategy:

• Use chicken brain cDNA library as a source (previously successful for isolating a 2.4-kilobase pair cDNA)

• Design primers based on conserved regions of the receptor

• Amplify the complete coding sequence

• Verify the open reading frame (expected to code for approximately 639 amino acids)

Expression systems:

• Cell lines: Chinese hamster ovary (CHO) cells have been successfully used for stable transfection

• Vector selection: Choose vectors with strong promoters appropriate for the host cell

• Selection markers: Include appropriate selection markers for stable transfection

• Tags: Consider adding epitope tags (His, FLAG) for purification and detection

Protein characterization:

• Confirm expression by Western blotting

• Verify binding properties using radioligand binding (typical binding parameters: Kd of approximately 76 pM for quinuclidinly benzilate)

• Assess functional coupling by measuring second messenger responses (cAMP, inositol phosphates)

• Determine antagonist binding profiles to confirm receptor identity

Proper folding and membrane insertion of the recombinant receptor are critical for maintaining functionality in experimental systems .

What are the critical considerations for designing ELISA-based detection methods for chicken CHRM3?

When designing or optimizing ELISA-based detection methods for chicken CHRM3, researchers should consider:

Assay specificity:

• Ensure no significant cross-reactivity with other chicken muscarinic receptor subtypes (M2, M4)

• Validate antibody specificity against recombinant standards

• Test for potential interference from sample matrix components

Performance parameters:

• Typical intra-assay precision (CV): <10%

• Typical inter-assay precision (CV): <10%

• Expected sensitivity: approximately 0.19 ng/ml

• Typical test range: 0.312 ng/ml - 20 ng/ml

Sample preparation:

• Optimize protocols for different sample types (serum, plasma, tissue homogenates)

• Consider the need for protein extraction buffers containing protease inhibitors

• Establish consistent homogenization procedures for tissue samples

Validation requirements:

• Standard curve linearity (r² > 0.99)

• Recovery experiments with spiked samples

• Reproducibility testing across operators and days

• Stability testing of critical reagents

How do genetic modifications of CHRM3 contribute to understanding its physiological role in chickens?

Genetic approaches offer powerful tools for investigating CHRM3 function:

Gene knockdown/knockout strategies:

• RNA interference (siRNA, shRNA) for transient knockdown studies

• CRISPR/Cas9 for stable genetic modifications

• Antisense oligonucleotides for targeted mRNA reduction

Expression manipulation:

• Overexpression studies using viral vectors

• Creation of chicken embryonic stem cells with modified CHRM3

• In ovo electroporation for embryonic studies

Reporter systems:

• Fusion proteins with fluorescent tags for localization studies

• Luciferase reporter assays for promoter studies (similar to those used for the cm2 promoter)

• Biosensors for real-time monitoring of receptor activation

Research has shown that the cm2 (M2) muscarinic receptor promoter region can drive expression in chicken heart primary cultures, suggesting similar approaches may be valuable for studying CHRM3 regulation. Cytokines like ciliary neurotrophic factor and leukemia inhibitory factor can influence muscarinic receptor expression, providing potential experimental tools for modulating CHRM3 levels .

The combination of these genetic approaches with pharmacological and physiological studies provides a comprehensive understanding of CHRM3's role in chicken physiology, particularly in the unique context of cardiac tissue that expresses multiple muscarinic receptor subtypes .